@KennethBogner https://t.co/jdxXqYQVQa
Hey Ken, this was a fantastic step in the right direction, but much more is needed. To many patients are dying in Phase 1 trials do too FDA mandated sub-optimal dosing.
@mkt_sentiment Bloomberg is for 1) rich Equity investors who don’t care about the cost and 2) bond investors for which there’s nothing even remotely similar
@elonmusk According to Grok
• Select Grok for real-time information, multimodal generation, cost-efficient scaling, or responses with minimal ideological filtering
• Select Claude for complex software engineering, enterprise document processing, long-horizon agentic automation